Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 4.77
- Piotroski Score 3.00
- Grade Buy
- Symbol (ETON)
- Company Eton Pharmaceuticals, Inc.
- Price $10.77
- Changes Percentage (3.24%)
- Change $0.34
- Day Low $10.21
- Day High $10.79
- Year High $11.11
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; and Rezipres, a ready-to-use formulation of a molecule that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia. It also offers Alkindi Sprinkle, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; EPRONTIA, a liquid formulation of topiramate; and Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis. In addition, the company develops Zonisamide Oral Suspension for the treatment of partial on-set seizures; Lamotrigine for Oral Suspension for the treatment of partial on-set seizures; cysteine injection; dehydrated alcohol injection; and Zeneo hydrocortisone autoinjector. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 03/13/2025
- Fiscal Year End N/A
- Average Stock Price Target $13.00
- High Stock Price Target $15.00
- Low Stock Price Target $11.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.03
- Trailing P/E Ratio 120.33
- Forward P/E Ratio 120.33
- P/E Growth 120.33
- Net Income $-936,000
Income Statement
Quarterly
Annual
Latest News of ETON
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Praised by Dutton, the man who almost led Australia says he leaves politics with failures that became the best of him | Karen Middleton
After 17 years in politics, Bill Shorten bids farewell, receiving praise from opponent Peter Dutton. Shorten reflects on his career, achievements, and the sacrifices made. He urges colleagues to be am...
By The Guardian | 17 hours ago -
Pendleton Whisky Releases Its First-Ever Bourbon
Pendleton Whisky, known for its rodeo heritage, adds a new American-distilled spirit to its lineup - the Pendleton 1910 Bourbon. Aged for 10 years, it offers a rich flavor profile and higher proof, ca...
By Forbes | 1 day ago -
VCU Rams face the Seton Hall Pirates
VCU will play against Seton Hall in Charleston, SC. VCU had a 24-14 record with 71.0 points per game, while Seton Hall finished 25-12 with opponents scoring 69.9 points per game....
By AP NEWS | 1 day ago
